DUALITYBIO-B 09606·

Gross margin 100.00%--76.06%23.94%40.42%35.64%31.81%8.61% Net margin -24193.12%---20.01%24173.11%-54.11%34.10%-140.13%86.02% ROE 50.33%--31.81%18.52%51.95%20.14%-106.93%158.88% ROA -83.47%---23.84%59.64%-50.25%26.42%-66.66%16.40% Revenue growth ----111558.75%--8.66%111550.09%-4.61%13.27% Attributable profit growth ----7.64%---193.82%201.46%-147.02%46.79% Debt-to-assets 265.85%--174.93%90.92%196.73%21.80%37.66%159.07% Current ratio 0.33--0.520.190.490.033.653.15 Operating cash flow / net profit 0.77---2.283.06-0.272.01-0.070.20 Operating cash flow / revenue -18716.88%--45.69%18762.57%14.72%30.97%10.51%4.21%

Gross margin 47.96%---106.40%154.36% Net margin -168.75%---418.34%249.59% Revenue growth -----82.15%-- Attributable profit growth ----55.76%-- Debt-to-assets ----58.63%-- Current ratio ----1.99-- Operating cash flow / net profit -0.28--0.460.75 Operating cash flow / revenue 47.99%---193.18%241.17%

Revenue 1.60M--1.79B111558.75%1.94B8.66%1.85B4.61% Other income and gains 494.00K--3.26M560.12%7.34M125.02%8.28M12.86% Gross profit 1.60M--1.36B84830.31%784.67M42.26%589.09M24.92% Administrative expenses 31.92M--62.57M96.01%158.69M153.64%214.61M35.23% Net finance costs 75.00K--188.00K150.67%250.00K32.98%1.21M384.00% Income tax ----155.26M--35.89M76.89%---- Operating profit -368.58M--781.36M311.99%-188.99M124.19%-486.87M157.61% Profit before tax -387.09M---202.25M47.75%-1.01B401.63%-2.59B155.76% Net profit -387.09M---357.51M7.64%-1.05B193.82%-2.59B147.02% Net profit attributable to owners -387.09M---357.51M7.64%-1.05B193.82%-2.59B147.02%

Revenue 1.23B--219.33M82.15% Other income and gains 1.09M--3.23M195.33% Cost of sales 639.53M--452.69M29.22% Gross profit 589.40M---233.36M139.59% Selling and distribution expenses 349.39M--606.67M73.64% Administrative expenses 125.55M--81.55M35.05% Net finance costs 573.00K--2.54M343.80% Income tax 0--0-- Operating profit 107.03M---966.90M1003.40% Profit before tax -2.07B---917.54M55.76% Net profit -2.07B---917.54M55.76% Net profit attributable to owners -2.07B---917.54M55.76%

Cash and cash equivalents 375.97M--1.13B200.79%1.21B6.90%1.28B5.58% Trade and bills receivables 1.41M--100.80M7059.30%379.02M276.00%277.92M26.68% Total current assets 404.88M--1.33B229.45%1.91B43.18%3.83B100.76% Total assets 463.74M--1.50B223.44%2.09B39.36%3.89B86.24% Total current liabilities 1.23B--2.56B108.10%3.87B51.16%1.05B72.83% Total liabilities 1.23B--2.62B112.83%4.11B56.72%1.47B64.34% Equity attributable to owners -769.12M---1.12B46.13%-2.02B79.90%2.43B220.02% Total equity -769.12M---1.12B46.13%-2.02B79.90%2.43B220.02%

Cash and cash equivalents ----2.27B-- Trade and bills receivables ----147.88M-- Total current assets ----3.46B-- Total assets ----3.51B-- Total current liabilities ----1.74B-- Total liabilities ----2.06B-- Equity attributable to owners ----1.45B-- Total equity ----1.45B--

Net cash from operating activities -299.47M--816.34M372.59%285.78M64.99%194.58M31.91% Net cash from investing activities -22.20M---78.55M253.83%-211.15M168.81%-1.91B805.78% Net cash from financing activities 451.46M--10.82M97.60%-7.62M170.45%1.81B23834.54% Net change in cash 129.79M--748.60M476.77%67.01M91.05%90.82M35.54%

Net cash from operating activities 589.76M---423.70M171.84% Net cash from investing activities -520.93M--1.30B349.40% Net cash from financing activities 1.73B--166.24M90.39% Net change in cash 1.80B--1.04B42.07%